Literature DB >> 23363468

Injection time-dependent effect of adult human bone marrow stromal cell transplantation in a rat model of severe traumatic brain injury.

Eun Young Han1, Min Ho Chun, Sang Tae Kim, Dong-pyo Lim.   

Abstract

The object of this study is to evaluate the effects of injecting adult human bone marrow stromal cells (hBMSCs) into rats with severe traumatic brain injury in acute phase and to determine more optimal injection timing between day 1 and day 2 postinjury. The lateral fluid percussion injury model was used. Adult hBMSCs were transplanted into hemisphere to injury sites in the corpus callosum ipsilateral on day 1 (n = 12) or day 7 (n = 8) after injury. A control group (n = 7) underwent only a sham operation without stem cell transplantation. Rats in all groups were analyzed by magnetic resonance spectroscopy (MRS), and by using behavioral, rotarod, and Barnes maze tests on day 1, 7, 14, and 42. Another nine randomly designated rats were sacrificed for immunohistochemical staining. Behavioral test scores increased significantly at all time-points after TBI in the day 7-injected group, compared to the others (p=0.008). GFAP staining was lower on day 42 in day 7-injected rats than in those injected on day 1. But no significant inter- or intra-group differences were observed for other tests. The injection of hBMSCs was found to have limited therapeutic potential with respect to neuroprotection after traumatic brain injury. However, because injection on day 7 after TBI produced greater functional improvements in neurobehavioral tests and more effectively suppressed astroglial activation than an injection on post-injury day 1, we cautiously recommend the injection time of day 7 post injury in hBMSCs transplantation in severe TBI, rather than day 1 post injury but further studies on developing hBMSC-based new therapeutic approaches should be warranted for improving neuroprotection in severe TBI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23363468     DOI: 10.2174/1574888x11308020008

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  5 in total

1.  Preclinical progenitor cell therapy in traumatic brain injury: a meta-analysis.

Authors:  Margaret L Jackson; Amit K Srivastava; Charles S Cox
Journal:  J Surg Res       Date:  2017-03-08       Impact factor: 2.192

2.  Three-dimensional-printed collagen/chitosan/secretome derived from HUCMSCs scaffolds for efficient neural network reconstruction in canines with traumatic brain injury.

Authors:  Xiaoyin Liu; Guijun Zhang; Pan Wei; Lin Zhong; Yaxing Chen; Jianyong Zhang; Xuyi Chen; Liangxue Zhou
Journal:  Regen Biomater       Date:  2022-06-27

Review 3.  Stem cell therapy for acute cerebral injury: what do we know and what will the future bring?

Authors:  Robin Lemmens; Gary K Steinberg
Journal:  Curr Opin Neurol       Date:  2013-12       Impact factor: 5.710

Review 4.  Systematic review and meta-analysis of efficacy of mesenchymal stem cells on locomotor recovery in animal models of traumatic brain injury.

Authors:  Weijun Peng; Jing Sun; Chenxia Sheng; Zhe Wang; Yang Wang; Chunhu Zhang; Rong Fan
Journal:  Stem Cell Res Ther       Date:  2015-03-26       Impact factor: 6.832

Review 5.  Developing stem cell therapies for juvenile and adult-onset Huntington's disease.

Authors:  Kyle D Fink; Peter Deng; Audrey Torrest; Heather Stewart; Kari Pollock; William Gruenloh; Geralyn Annett; Teresa Tempkin; Vicki Wheelock; Jan A Nolta
Journal:  Regen Med       Date:  2015       Impact factor: 3.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.